MOVOFLEX^® Advanced Soft Chews Joint Supplement for dogs

 

Help your canine patients power through
their adult years
 

See the research

 

EFFECTIVE
See results in as little as one week¹ with no loading period

SAFE
Safety studied at 5x recommended use¹

EASY ADMINISTRATION
95% acceptability¹

 

7 POWERFULLY SYNERGISTIC INGREDIENTS

Support for overall mobility structure and flexibility, as well as bone health
 

Biovaflex^® Eggshell Membrane
Elemental source of collagen, elastin and GAGs to support joint structure and flexibility.²
 

Astaxanthin
Powerful antioxidant providing protection from free radicals and nitric oxide.³

Boswellic Acid from Boswellia Serrata
Decreases normal inflammatory pathways and supports structural integrity of joints and connective tissues.⁴

Vitamin D3
Supports bone health.

High Molecular Weight Hyaluronic Acid (HA)
Supports joint flexibility and viscosity of synovial fluids.⁵

Krill
Source of Omega-3 fatty acids in a
form bound to phospholipids, shown
to improve absorption of astaxanthin
and HA.^6,7

Low Molecular Weight Hyaluronic Acid (HA)
Supports and maintains joint structure
when combined with krill and astaxanthin.^8,9
 

 

 

 

One tasty chicken-flavored soft chew per day.

• 60 soft chews per jar
• Available for small, medium and large dogs

 

 

 

Expanding mobility protocols to
help support quality of life.

Your Virbac representative will be happy to visit your clinic, answer questions and
talk with you about how MOVOFLEX^® Advanced Soft Chews can complement your
existing mobility protocol.

MOVOFLEX^® Advanced Soft Chews Materials

For your health care team:

• MOVOFLEX Advanced Soft Chews Vet Detailer
• Satisfaction Guarantee

 

For your clients

• MOVOFLEX Advanced Soft Chews Pet Owner Brochure
• MOVOFLEX Advanced Soft Chews Pet Owner Rebate
• MOVOFLEX Advanced Soft Chews Pet Owner Video

 

---

 

References:

1. Data on file. Virbac Corporation. 
2. Responsibly sourced water-soluble eggshell membrane. Biova. https://www.biova.com/sustainability/. Accessed January 30, 2026. 
3. Pashtow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol. 2008;101(10A):58D-68D. doi: 10.1016/j.amjcard.2008.02.010 
4. Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 2011;50(6):349-369. doi: 10.2165/11586800-000000000-00000 
5. Balogh L, Polyak A, Mathe D, et al. Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs. J Agric Food Chem. 2008;56(22):10582-10593. doi: 10.1021/jf8017029 
6. Mercke Odeberg J, Lignell A, Pettersson A, Höglund P. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci. 2003;19(4):299-304. doi:10.1016/s0928-0987(03)00135-0 
7. Huang SL, Ling PX, Zhang TM. Oral absorption of hyaluronic acid and phospholipids complexes in rats. World J Gastroenterol. 2007;13(6):945-949. doi:10.3748/wjg.v13.i6.945 
8. Park DR, Ko R, Kwon SH, et al. FlexPro MD^®, a mixture of krill oil, astaxanthin, and hyaluronic acid, suppresses lipopolysaccharide-induced inflammatory cytokine production through inhibition of NF-кB. J Med Food. 2016;19(12):1196-1203. doi:10.1089/jmf.2016.3787 
9. Park MH, Jung JC, Hill S, et al. FlexPro MD^®, a combination of krill oil, astaxanthin and hyaluronic acid, reduces pain behavior and inhibits inflammatory response in monosodium iodoacetate-induced osteoarthritis in rats. Nutrients. 2020;12(4):956. doi:10.3390/nu12040956

©2026 Virbac Corporation. MOVOFLEX is a registered trademark of the Virbac Group of Companies. BiovaFlex is a registered trademark of Biova, LLC. All rights reserved. 04/26